More data, this time from a large observational study, are bolstering the idea that glucagon-like peptide-1 (GLP-1) receptor ...

Popular GLP-1 drugs help many people drop tremendous amounts of weight, but the drugs fail to provide a key improvement in ...

There have already been reports of individuals having adverse reactions to these copycat drugs — with some requiring hospitalization and others leading to death. Consumers should be able to trust that ...

A recipient of the 2025 Elite Trial Lawyers Lifetime Achievement Award, Morgan & Morgan's John Yanchunis spoke with the National Law Journal about his storied career, from bringing one of the nation’s ...

But, as my doctor explained, this was about the impact of carrying extra body weight on my joints. Given my lifelong struggles with dieting, he suggested there might be an underlying issue ...

At the intersection of aesthetics and science, RegenCen is changing how patients think about aging. Born from a fusion of ...

DexCom focuses on continuous glucose monitoring systems, with a strong market position and global reach. Click here to read ...

Pfizer and Novo Nordisk have underperformed the market over the past year. Pharmaceutical giants Pfizer (NYSE: PFE) and Novo ...

Mounjaro side effect explained as more than 220,000 Brits are expected to receive the drug over the next three years ...

For patients with idiopathic intracranial hypertension (IIH), glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is associated with improved clinical outcomes compared with conventional ...

Popular GLP-1 drugs help many people drop tremendous amounts of weight, but the drugs fail to provide a key improvement in ...

A new study published by Cleveland Clinic researchers in Diabetes, Obesity and Metabolism investigating the genetic ...